| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |